Leaflet: information for the patient
Silodyx 8 mg hard capsules
Silodyx 4 mg hard capsules
Silodosina
Read this leaflet carefully before you start taking this medicine, because it contains important information for you.
What is Silodyx
Silodyx belongs to a group of medications known as alpha 1A adrenergic receptor blockers.
Silodyx is selective for receptors located in the prostate, bladder, and urethra. By blocking these receptors, it causes relaxation of the smooth muscle in these tissues. This makes it easier for you to urinate and alleviates your symptoms.
What is Silodyx used for
Silodyx is used in adult males to treat urinary symptoms associated with benign prostatic hyperplasia (BPH), such as:
Do not take Silodyx
if you are allergic to silodosin or any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
Consult your doctor or pharmacist before starting to take Silodyx.
When taking Silodyx, dizziness and, occasionally, fainting may occur when standing up, especially when starting treatment or taking other medications that lower blood pressure. If this happens,sit or lie downimmediately until the symptoms disappear andinform your doctor as soon as possible(see also the section “Driving and operating machines”).
If your kidney problems are moderate, your doctor will start treatment with Silodyx with caution and possibly with a lower dose (see section 3 “Doses”).
If your kidney problems are severe, do not take Silodyx.
Silodyx contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per capsule; it is essentially “sodium-free”.
Children and adolescents
Do not administer this medicine to children and adolescents under 18 years of age, as there are no relevant indications for this age group.
Taking Silodyx with other medicines
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine.
Inform your doctorin particular if you take:
Pregnancy and breastfeeding
Silodyx is not intended for use by women.
Fertility
Silodyx may reduce semen volume and temporarily affect your ability to conceive a child. If you intend to have a child, consult your doctor or pharmacist before using this medicine.
Driving and operating machines
Do not drive or operate machines if you feel dizziness, dizziness, or somnolence or have blurred vision.
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
The recommended dose is one Silodyx 8 mg capsule per day taken orally.
Take the capsule always accompanied by food, preferably at the same time every day. Do not break or chew the capsule; swallow it whole, preferably with a glass of water.
Patients with kidney problems
If you have moderate kidney problems, your doctor may prescribe a different dose.
To this end, the Silodyx 4 mg hard capsules presentation is available.
If you take more Silodyx than you should
If you have taken more than one capsule, inform your doctor as soon as possible. If you experience dizziness or feel weak, inform your doctor immediately.
If you forget to take Silodyx
You can take the capsule later the same day if you forgot to take it earlier. If it is almost time for the next dose, do not take the missed dose. Do not take a double dose to make up for the missed capsule.
If you interrupt treatment with Silodyx
If you interrupt treatment, it is possible that symptoms will reappear.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Immediately contact your doctor if you experience any of the following allergic reactions, as their consequences could be severe: swelling of the face or throat, difficulty breathing, feeling of fainting, itching on the skin or urticaria.
The most common side effect is a reduction in the amount of semen expelled during sexual intercourse. This side effect disappears after stopping treatment with Silodyx. Inform your doctor if you are planning to have children.
You may experiencedizziness, including dizziness when standing up, and, occasionally,fainting.
If you feel weakness or dizziness,sit or lie downimmediately until the symptoms disappear. If you experience dizziness when standing up or fainting,inform your doctor as soon as possible.
Silodyx may cause complications duringcataract surgery(eye surgery for cloudy lens; see "Warnings and precautions").
It is essential thatyou inform your ophthalmologist immediatelyif you are using or have used Silodyx previously.
The possible side effects are listed below:
Very common side effects (may affect more than 1 in 10 people)
Common side effects (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
Rare side effects (may affect up to 1 in 1,000 people)
Very rare side effects (may affect up to 1 in 10,000 people)
Unknown frequency (frequency cannot be estimated from available data)
Inform your doctor if you notice that your sexual relations are affected.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through thenational notification system included in theAppendix V. By reporting side effects, you can contribute to providing more information about the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box and on the blister pack after “CAD”. The expiration date is the last day of the month indicated.
Do not store above 86°F (30°C).
Store in the original packaging to protect it from light and moisture.
Do not use this medication if you observe that the packaging is damaged or shows signs of having been improperly handled.
Medications should not be disposed of through drains or in the trash. Ask your pharmacist how to dispose of the packaging and medications that you no longer need. This will help protect the environment.
Composition of Silodyx
Silodyx 8 mg
The active ingredient is silodosin. Each capsule contains 8 mg of silodosin.
The other components are pregelatinized maize starch, mannitol (E421), magnesium stearate, sodium lauryl sulfate, gelatin, titanium dioxide (E171).
Silodyx 4 mg
The active ingredient is silodosin. Each capsule contains 4 mg of silodosin.
The other components are pregelatinized maize starch, mannitol (E421), magnesium stearate, sodium lauryl sulfate, gelatin, titanium dioxide (E171), yellow iron oxide (E172).
Appearance of the product and contents of the pack
Silodyx 8 mg are hard gelatin capsules, opaque and white, size 0 (21.7 x 7.6 mm, approximately).
Silodyx 4 mg are hard gelatin capsules, opaque and yellow, size 3 (15.9 x 5.8 mm, approximately).
Silodyx is available in packs of 5, 10, 20, 30, 50, 90 and 100 capsules and in multiple packs with 2 packs of 100 capsules each. Some pack sizes may not be marketed.
Marketing Authorization Holder
Recordati Ireland Ltd.
Raheens East
Ringaskiddy Co. Cork
Ireland
Responsible Person
Recordati Industria Chimica e Farmaceutica S.p.A.
Via Matteo Civitali 1
20148 Milan
Italy
Laboratoires Bouchara-Recordati
Parc Mécatronic
03410 Saint Victor
France
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
België/Belgique/Belgien Recordati bv Tel: +32 2 461 01 36 | Lietuva Recordati Ireland Ltd. Tel: + 353 21 4379400 |
Recordati Ireland Ltd Tel: + 353 21 4379400 | Luxembourg/Luxemburg Recordati bv Tel: +32 2 461 01 36 |
Ceská republika Recordati Ireland Ltd. Tel: + 353 21 4379400 | Magyarország Recordati Ireland Ltd. Tel: + 353 21 4379400 |
Danmark Recordati Ireland Ltd. Tel: + 353 21 4379400 | Malta Recordati Ireland Ltd. Tel: + 353 21 4379400 |
Deutschland Recordati Ireland Ltd. Tel: + 353 21 4379400 | Nederland Recordati bv Tel: +32 2 461 01 36 |
Eesti Recordati Ireland Ltd. Tel: + 353 21 4379400 | Norge Recordati Ireland Ltd. Tel: + 353 21 4379400 |
Ελλάδα ΒΙΑΝΕΞ Α.Ε. Tel: + 30 210 8009111 | Österreich Recordati Ireland Ltd. Tel: + 353 21 4379400 |
España Almirall, S.A. Tel: +34 93 291 30 00 | Polska Recordati Ireland Ltd. Tel: + 353 21 4379400 |
France ZAMBON France Tel: + 33 (0)1 58 04 41 41 | Portugal Tecnimede Sociedade Técnico-Medicinal, S.A Tel: +351 21 041 41 00 |
Hrvatska Recordati Ireland Ltd. Tel: + 353 21 4379400 | România Recordati Ireland Ltd. Tel: + 353 21 4379400 |
Ireland Recordati Ireland Ltd. Tel: + 353 21 4379400 | Slovenija Recordati Ireland Ltd. Tel: + 353 21 4379400 |
Ísland Recordati Ireland Ltd. Tel: + 353 21 4379400 | Slovenská republika Recordati Ireland Ltd. Tel: + 353 21 4379400 |
Italia Takeda Italia S.p.A. Tel: + 39 06 502601 | Suomi/Finland Recordati Ireland Ltd. Tel: + 353 21 4379400 |
Κύπρος Recordati Ireland Ltd. Tel: + 353 21 4379400 | Sverige Recordati Ireland Ltd. Tel: + 353 21 4379400 |
Latvija Recordati Ireland Ltd. Tel: + 353 21 4379400 | United Kingdom (Northern Ireland) Recordati Ireland Ltd. Tel: + 353 21 4379400 |
Last update of this leaflet
Other sources of information
The detailed information on this medicine is available on the website of the European Medicines Agency:http://www.ema.europa.eu.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.